Journal of colloid and interface science

[1] Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells.

[2] the secret role of micrornas in cancer stem cell development and potential therapy: a notch-pathway approach.

[3] the wheat bax inhibitor-1 protein interacts with an aquaporin tapip1 and enhances disease resistance in arabidopsis

[4] modulating dickkopf-1: a strategy to monitor or treat cancer?

[5] Nanomaterials multifunctional behavior for enlighten cancer therapeutics.

[6] Bacterial magnetosomes-based nanocarriers for co-delivery of cancer therapeutics in vitro

[7] Small molecule PIKfyve inhibitors as cancer therapeutics: Translational promises and limitations.

[8] Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1.

[9] Anticonvulsant valproic acid and other short-chain fatty acids as novel anticancer therapeutics: Possibilities and challenges.

[10] Targeting the Fanconi Anemia Pathway to Identify Tailored Anticancer Therapeutics

[11] erbb polymorphisms: insights and implications for response to targeted cancer therapeutics

[12] voltage-dependent anion channel 1 as an emerging drug target for novel anti-cancer therapeutics

[13] mechanistic systems modeling to improve understanding and prediction of cardiotoxicity caused by targeted cancer therapeutics

[14] the role of heparanase and sulfatases in the modification of heparan sulfate proteoglycans within the tumour microenvironment and opportunities for novel cancer therapeutics

[15] gold nanostructures as a platform for combinational therapy in future cancer therapeutics